HEADER TRANSPORT PROTEIN 26-OCT-21 7VSI TITLE STRUCTURE OF HUMAN SGLT2-MAP17 COMPLEX BOUND WITH EMPAGLIFLOZIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: SODIUM/GLUCOSE COTRANSPORTER 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NA(+)/GLUCOSE COTRANSPORTER 2,LOW AFFINITY SODIUM-GLUCOSE COMPND 5 COTRANSPORTER,SOLUTE CARRIER FAMILY 5 MEMBER 2; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PDZK1-INTERACTING PROTEIN 1; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: 17 KDA MEMBRANE-ASSOCIATED PROTEIN,PROTEIN DD96; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC5A2, SGLT2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: PDZK1IP1, MAP17; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS GLUCOSE TRANSPORTER, SGLT2, SGLT, TRANSPORT PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR L.CHEN,Y.NIU,R.LIU REVDAT 3 16-FEB-22 7VSI 1 JRNL REVDAT 2 22-DEC-21 7VSI 1 JRNL REVDAT 1 15-DEC-21 7VSI 0 SPRSDE 15-DEC-21 7VSI 7FEN JRNL AUTH Y.NIU,R.LIU,C.GUAN,Y.ZHANG,Z.CHEN,S.HOERER,H.NAR,L.CHEN JRNL TITL STRUCTURAL BASIS OF INHIBITION OF THE HUMAN SGLT2-MAP17 JRNL TITL 2 GLUCOSE TRANSPORTER. JRNL REF NATURE V. 601 280 2022 JRNL REFN ESSN 1476-4687 JRNL PMID 34880493 JRNL DOI 10.1038/S41586-021-04212-9 REMARK 2 REMARK 2 RESOLUTION. 2.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : RELION REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.950 REMARK 3 NUMBER OF PARTICLES : 36375 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7VSI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1300025299. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HUMAN SGLT2-MAP17 COMPLEX REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 SUMMIT (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : SPOT SCAN REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 GLU A 3 REMARK 465 HIS A 4 REMARK 465 THR A 5 REMARK 465 GLU A 6 REMARK 465 ALA A 7 REMARK 465 GLY A 8 REMARK 465 SER A 9 REMARK 465 ALA A 10 REMARK 465 PRO A 11 REMARK 465 GLU A 12 REMARK 465 MET A 13 REMARK 465 GLY A 14 REMARK 465 ALA A 15 REMARK 465 GLN A 16 REMARK 465 LYS A 17 REMARK 465 ALA A 18 REMARK 465 LEU A 19 REMARK 465 ILE A 20 REMARK 465 ALA A 575 REMARK 465 ASP A 576 REMARK 465 GLU A 577 REMARK 465 GLN A 578 REMARK 465 GLN A 579 REMARK 465 GLY A 580 REMARK 465 SER A 581 REMARK 465 SER A 582 REMARK 465 LEU A 583 REMARK 465 PRO A 584 REMARK 465 VAL A 585 REMARK 465 GLN A 586 REMARK 465 ASN A 587 REMARK 465 GLY A 588 REMARK 465 CYS A 589 REMARK 465 PRO A 590 REMARK 465 GLU A 591 REMARK 465 SER A 592 REMARK 465 ALA A 593 REMARK 465 MET A 594 REMARK 465 GLU A 595 REMARK 465 MET A 596 REMARK 465 ASN A 597 REMARK 465 GLU A 598 REMARK 465 PRO A 599 REMARK 465 GLN A 600 REMARK 465 ALA A 601 REMARK 465 PRO A 602 REMARK 465 ALA A 603 REMARK 465 PRO A 604 REMARK 465 SER A 605 REMARK 465 LEU A 606 REMARK 465 PHE A 607 REMARK 465 ARG A 608 REMARK 465 GLN A 609 REMARK 465 CYS A 610 REMARK 465 LEU A 611 REMARK 465 LEU A 612 REMARK 465 TRP A 613 REMARK 465 PHE A 614 REMARK 465 CYS A 615 REMARK 465 GLY A 616 REMARK 465 MET A 617 REMARK 465 SER A 618 REMARK 465 ARG A 619 REMARK 465 GLY A 620 REMARK 465 GLY A 621 REMARK 465 VAL A 622 REMARK 465 GLY A 623 REMARK 465 SER A 624 REMARK 465 PRO A 625 REMARK 465 PRO A 626 REMARK 465 PRO A 627 REMARK 465 LEU A 628 REMARK 465 THR A 629 REMARK 465 GLN A 630 REMARK 465 GLU A 631 REMARK 465 GLU A 632 REMARK 465 ALA A 633 REMARK 465 ALA A 634 REMARK 465 ALA A 635 REMARK 465 ALA A 636 REMARK 465 ALA A 637 REMARK 465 ARG A 638 REMARK 465 ARG A 639 REMARK 465 LEU A 640 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 ALA B 3 REMARK 465 LEU B 4 REMARK 465 SER B 5 REMARK 465 LEU B 6 REMARK 465 LEU B 7 REMARK 465 ILE B 8 REMARK 465 LEU B 9 REMARK 465 GLY B 10 REMARK 465 LEU B 11 REMARK 465 LEU B 12 REMARK 465 THR B 13 REMARK 465 ALA B 14 REMARK 465 VAL B 15 REMARK 465 PRO B 16 REMARK 465 PRO B 17 REMARK 465 ALA B 18 REMARK 465 SER B 19 REMARK 465 CYS B 20 REMARK 465 GLN B 21 REMARK 465 GLN B 22 REMARK 465 GLY B 23 REMARK 465 LEU B 24 REMARK 465 GLY B 25 REMARK 465 GLN B 56 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 21 CG OD1 OD2 REMARK 470 ASP A 25 CG OD1 OD2 REMARK 470 THR A 47 OG1 CG2 REMARK 470 ASN A 48 CG OD1 ND2 REMARK 470 GLU A 244 CG CD OE1 OE2 REMARK 470 ASP A 245 CG OD1 OD2 REMARK 470 SER A 510 OG REMARK 470 GLU A 641 CG CD OE1 OE2 REMARK 470 ASP A 642 CG OD1 OD2 REMARK 470 ASN B 26 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 48 60.99 60.95 REMARK 500 LEU A 57 11.08 -141.02 REMARK 500 SER A 91 -64.38 -93.04 REMARK 500 ALA A 94 -36.58 -39.06 REMARK 500 LYS A 154 -56.11 -120.10 REMARK 500 ALA A 236 32.11 -95.06 REMARK 500 SER A 510 -169.98 -103.01 REMARK 500 ASP A 572 70.10 60.00 REMARK 500 ASP A 642 65.35 61.29 REMARK 500 TYR A 671 37.80 -98.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PLM A 702 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-31558 RELATED DB: EMDB DBREF 7VSI A 1 672 UNP P31639 SC5A2_HUMAN 1 672 DBREF 7VSI B 1 56 UNP Q13113 PDZ1I_HUMAN 1 56 SEQRES 1 A 672 MET GLU GLU HIS THR GLU ALA GLY SER ALA PRO GLU MET SEQRES 2 A 672 GLY ALA GLN LYS ALA LEU ILE ASP ASN PRO ALA ASP ILE SEQRES 3 A 672 LEU VAL ILE ALA ALA TYR PHE LEU LEU VAL ILE GLY VAL SEQRES 4 A 672 GLY LEU TRP SER MET CYS ARG THR ASN ARG GLY THR VAL SEQRES 5 A 672 GLY GLY TYR PHE LEU ALA GLY ARG SER MET VAL TRP TRP SEQRES 6 A 672 PRO VAL GLY ALA SER LEU PHE ALA SER ASN ILE GLY SER SEQRES 7 A 672 GLY HIS PHE VAL GLY LEU ALA GLY THR GLY ALA ALA SER SEQRES 8 A 672 GLY LEU ALA VAL ALA GLY PHE GLU TRP ASN ALA LEU PHE SEQRES 9 A 672 VAL VAL LEU LEU LEU GLY TRP LEU PHE ALA PRO VAL TYR SEQRES 10 A 672 LEU THR ALA GLY VAL ILE THR MET PRO GLN TYR LEU ARG SEQRES 11 A 672 LYS ARG PHE GLY GLY ARG ARG ILE ARG LEU TYR LEU SER SEQRES 12 A 672 VAL LEU SER LEU PHE LEU TYR ILE PHE THR LYS ILE SER SEQRES 13 A 672 VAL ASP MET PHE SER GLY ALA VAL PHE ILE GLN GLN ALA SEQRES 14 A 672 LEU GLY TRP ASN ILE TYR ALA SER VAL ILE ALA LEU LEU SEQRES 15 A 672 GLY ILE THR MET ILE TYR THR VAL THR GLY GLY LEU ALA SEQRES 16 A 672 ALA LEU MET TYR THR ASP THR VAL GLN THR PHE VAL ILE SEQRES 17 A 672 LEU GLY GLY ALA CYS ILE LEU MET GLY TYR ALA PHE HIS SEQRES 18 A 672 GLU VAL GLY GLY TYR SER GLY LEU PHE ASP LYS TYR LEU SEQRES 19 A 672 GLY ALA ALA THR SER LEU THR VAL SER GLU ASP PRO ALA SEQRES 20 A 672 VAL GLY ASN ILE SER SER PHE CYS TYR ARG PRO ARG PRO SEQRES 21 A 672 ASP SER TYR HIS LEU LEU ARG HIS PRO VAL THR GLY ASP SEQRES 22 A 672 LEU PRO TRP PRO ALA LEU LEU LEU GLY LEU THR ILE VAL SEQRES 23 A 672 SER GLY TRP TYR TRP CYS SER ASP GLN VAL ILE VAL GLN SEQRES 24 A 672 ARG CYS LEU ALA GLY LYS SER LEU THR HIS ILE LYS ALA SEQRES 25 A 672 GLY CYS ILE LEU CYS GLY TYR LEU LYS LEU THR PRO MET SEQRES 26 A 672 PHE LEU MET VAL MET PRO GLY MET ILE SER ARG ILE LEU SEQRES 27 A 672 TYR PRO ASP GLU VAL ALA CYS VAL VAL PRO GLU VAL CYS SEQRES 28 A 672 ARG ARG VAL CYS GLY THR GLU VAL GLY CYS SER ASN ILE SEQRES 29 A 672 ALA TYR PRO ARG LEU VAL VAL LYS LEU MET PRO ASN GLY SEQRES 30 A 672 LEU ARG GLY LEU MET LEU ALA VAL MET LEU ALA ALA LEU SEQRES 31 A 672 MET SER SER LEU ALA SER ILE PHE ASN SER SER SER THR SEQRES 32 A 672 LEU PHE THR MET ASP ILE TYR THR ARG LEU ARG PRO ARG SEQRES 33 A 672 ALA GLY ASP ARG GLU LEU LEU LEU VAL GLY ARG LEU TRP SEQRES 34 A 672 VAL VAL PHE ILE VAL VAL VAL SER VAL ALA TRP LEU PRO SEQRES 35 A 672 VAL VAL GLN ALA ALA GLN GLY GLY GLN LEU PHE ASP TYR SEQRES 36 A 672 ILE GLN ALA VAL SER SER TYR LEU ALA PRO PRO VAL SER SEQRES 37 A 672 ALA VAL PHE VAL LEU ALA LEU PHE VAL PRO ARG VAL ASN SEQRES 38 A 672 GLU GLN GLY ALA PHE TRP GLY LEU ILE GLY GLY LEU LEU SEQRES 39 A 672 MET GLY LEU ALA ARG LEU ILE PRO GLU PHE SER PHE GLY SEQRES 40 A 672 SER GLY SER CYS VAL GLN PRO SER ALA CYS PRO ALA PHE SEQRES 41 A 672 LEU CYS GLY VAL HIS TYR LEU TYR PHE ALA ILE VAL LEU SEQRES 42 A 672 PHE PHE CYS SER GLY LEU LEU THR LEU THR VAL SER LEU SEQRES 43 A 672 CYS THR ALA PRO ILE PRO ARG LYS HIS LEU HIS ARG LEU SEQRES 44 A 672 VAL PHE SER LEU ARG HIS SER LYS GLU GLU ARG GLU ASP SEQRES 45 A 672 LEU ASP ALA ASP GLU GLN GLN GLY SER SER LEU PRO VAL SEQRES 46 A 672 GLN ASN GLY CYS PRO GLU SER ALA MET GLU MET ASN GLU SEQRES 47 A 672 PRO GLN ALA PRO ALA PRO SER LEU PHE ARG GLN CYS LEU SEQRES 48 A 672 LEU TRP PHE CYS GLY MET SER ARG GLY GLY VAL GLY SER SEQRES 49 A 672 PRO PRO PRO LEU THR GLN GLU GLU ALA ALA ALA ALA ALA SEQRES 50 A 672 ARG ARG LEU GLU ASP ILE SER GLU ASP PRO SER TRP ALA SEQRES 51 A 672 ARG VAL VAL ASN LEU ASN ALA LEU LEU MET MET ALA VAL SEQRES 52 A 672 ALA VAL PHE LEU TRP GLY PHE TYR ALA SEQRES 1 B 56 MET SER ALA LEU SER LEU LEU ILE LEU GLY LEU LEU THR SEQRES 2 B 56 ALA VAL PRO PRO ALA SER CYS GLN GLN GLY LEU GLY ASN SEQRES 3 B 56 LEU GLN PRO TRP MET GLN GLY LEU ILE ALA VAL ALA VAL SEQRES 4 B 56 PHE LEU VAL LEU VAL ALA ILE ALA PHE ALA VAL ASN HIS SEQRES 5 B 56 PHE TRP CYS GLN HET PLM A 701 17 HET PLM A 702 13 HET 7R3 A 703 31 HETNAM PLM PALMITIC ACID HETNAM 7R3 (2S,3R,4R,5S,6R)-2-[4-CHLORANYL-3-[[4-[(3S)-OXOLAN-3- HETNAM 2 7R3 YL]OXYPHENYL]METHYL]PHENYL]-6-(HYDROXYMETHYL)OXANE-3, HETNAM 3 7R3 4,5-TRIOL HETSYN 7R3 EMPAGLIFLOZIN FORMUL 3 PLM 2(C16 H32 O2) FORMUL 5 7R3 C23 H27 CL O7 HELIX 1 AA1 ASN A 22 ASN A 48 1 27 HELIX 2 AA2 THR A 51 PHE A 56 1 6 HELIX 3 AA3 LEU A 57 SER A 61 5 5 HELIX 4 AA4 VAL A 63 ILE A 76 1 14 HELIX 5 AA5 GLY A 77 SER A 91 1 15 HELIX 6 AA6 GLY A 92 ALA A 94 5 3 HELIX 7 AA7 VAL A 95 LEU A 112 1 18 HELIX 8 AA8 LEU A 112 GLY A 121 1 10 HELIX 9 AA9 THR A 124 PHE A 133 1 10 HELIX 10 AB1 ARG A 136 LYS A 154 1 19 HELIX 11 AB2 LYS A 154 LEU A 170 1 17 HELIX 12 AB3 ILE A 174 GLY A 224 1 51 HELIX 13 AB4 GLY A 225 TYR A 233 1 9 HELIX 14 AB5 PRO A 275 SER A 293 1 19 HELIX 15 AB6 ASP A 294 CYS A 301 1 8 HELIX 16 AB7 SER A 306 LEU A 322 1 17 HELIX 17 AB8 THR A 323 TYR A 339 1 17 HELIX 18 AB9 TYR A 339 ALA A 344 1 6 HELIX 19 AC1 VAL A 347 CYS A 355 1 9 HELIX 20 AC2 ILE A 364 MET A 374 1 11 HELIX 21 AC3 PRO A 375 ARG A 414 1 40 HELIX 22 AC4 GLY A 418 ALA A 446 1 29 HELIX 23 AC5 GLY A 450 VAL A 477 1 28 HELIX 24 AC6 ASN A 481 GLY A 507 1 27 HELIX 25 AC7 PRO A 518 GLY A 523 1 6 HELIX 26 AC8 HIS A 525 CYS A 547 1 23 HELIX 27 AC9 PRO A 552 LEU A 556 5 5 HELIX 28 AD1 VAL A 560 ARG A 564 5 5 HELIX 29 AD2 ASP A 646 TYR A 671 1 26 HELIX 30 AD3 GLN B 28 TRP B 54 1 27 SSBOND 1 CYS A 255 CYS A 511 1555 1555 2.06 SSBOND 2 CYS A 345 CYS A 351 1555 1555 2.04 SSBOND 3 CYS A 355 CYS A 361 1555 1555 2.03 SSBOND 4 CYS A 517 CYS A 522 1555 1555 2.04 LINK SG CYS A 45 C1 PLM A 702 1555 1555 1.78 LINK SG CYS A 547 C1 PLM A 701 1555 1555 1.77 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000